C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2004
12/02/2004	WO2004104209A1 Process for producing extract for cell-free protein synthesis and cell extract produced thereby
12/02/2004	WO2004104208A1 In vitro synthetic method for heparan chain and use thereof
12/02/2004	WO2004104201A1 Antifreezing protein found in fish
12/02/2004	WO2004104194A1 Compositions and methods for site-specific recombination and expression
12/02/2004	WO2004104182A1 Bioactive peptide-producing strains of enterococcus faecalis, bioactive peptides and applications thereof
12/02/2004	WO2004104170A2 Tools for detecting moraxella catarrhalis.
12/02/2004	WO2004104036A1 Process for producing soyeban whey protein and digested soybean whey protein
12/02/2004	WO2004103293A2 Modulators of the p2y10 receptor useful in altering t lymphocyte function
12/02/2004	WO2004081174A3 Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker
12/02/2004	WO2004074497A3 Endomannosidases in the modification of glycoproteins in eukaryotes
12/02/2004	WO2004005221A3 Benzoate- and anthranilate-inducible promoters
12/02/2004	WO2003085377A3 Novel pancortin-pablo protein interactions and methods of use thereof
12/02/2004	WO2003063767A3 Rsv proteins, antibodies, compositions, methods and uses
12/02/2004	WO2003056020A8 Expression vectors and promoters for heterologous gene expression
12/02/2004	WO2003027240A3 Rhesus monkey, dog and ferret melanin-concentrating hormone type 1 receptor
12/02/2004	WO2003011106A3 Internal image antibodies for optical imaging and therapy
12/02/2004	WO2002068583A3 Enzymes having dehalogenase activity and methods of use thereof
12/02/2004	US20040242860 Compositions and methods for the diagnosis and treatment of tumor
12/02/2004	US20040242859 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
12/02/2004	US20040242851 Immunoglobulin specifiic for vascular endothelial growth factor receptor for use in treatment and prevention of tumor; angiogenesis inhibitors; antitumor agents; antimetastasis agents; immunotherapy
12/02/2004	US20040242844 Nucleotide sequences coding streptococcus capsular polysaccharide antigens for use in diagnosis and prevention of infections in mammals; veterinary medicine
12/02/2004	US20040242843 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/02/2004	US20040242637 drugs used for signal transduction modulation, and for prophylaxis of angiogenesis, cancers, tumors, atherosclerosis, vision disorders and inflammatory diseases in mammals
12/02/2004	US20040242512 Novel vectors for animal cells and utilization thereof
12/02/2004	US20040242484 Specific polypeptides, useful as nematocides
12/02/2004	US20040241853 Introducing one or more mutations into a template double-stranded polynucleotide via hybridization, replication and amplification of random genomic double stranded and heterozygous oligonucleotides sequences; genomics and directed evolution
12/02/2004	US20040241817 Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function
12/02/2004	US20040241807 Interleukin-1 related gene and protein
12/02/2004	US20040241805 Cell surface binding protein for use in treatment, diagnosis and prevention of cancer, inflammation, autoimmunity, allergy, asthma and nervous system disorders
12/02/2004	US20040241803 25 human secreted proteins
12/02/2004	US20040241800 Vascular endothelial growth factor dimers
12/02/2004	US20040241791 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue
12/02/2004	US20040241740 Lafora's disease gene
12/02/2004	US20040241710 Methods of detecting colorectal cancer
12/02/2004	US20040241694 Using expression patter of neurodegenerative marker to diagnose/prognose brain disorders
12/02/2004	US20040241671 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their us as medicines
12/02/2004	US20040241664 Protein Hydrolysates Enriched In Peptides Having A Carboxy Terminal Proline Residue
12/02/2004	US20040241650 Computer-directed assembly of a polynucleotide encoding a target polypeptide
12/02/2004	US20040241647 Using aspergillus or trichoderma as bioreactors for expression of heterologous gene expression
12/02/2004	US20040241641 Monoclonal antibody for prevention and treatment of human immunodeficiency viral infection; immunotherapy
12/02/2004	US20040241639 Human tachykinin-related splice variants and compositions thereof
12/02/2004	US20040241182 lymphocytes; immunogens; fusion proteins; for treatment/prevention of infection
12/02/2004	US20040241165 RFamide-Related Peptide-3 (RFRP-3); orphan g protein coupled receptors; for promoting prolactin secretion; treating hypoovarianism, seminal vesicle hypoplasia, menopausal syndrome and hypothyroidism
12/02/2004	DE10326689A1 Anreicherung von enzymatischen Spaltprodukten Enhancement of enzymatic cleavage products
12/02/2004	CA2526661A1 Diagnostic kit for liver cirrhosis comprising an antibody specific for human protooncogenic protein
12/02/2004	CA2525954A1 Ura5 gene and methods for stable genetic integration in yeast
12/02/2004	CA2525840A1 Ovr115 antibody composition and methods of use
12/02/2004	CA2525831A1 Process for manufacture of nematode-extracted anticoagulant protein (nap)
12/02/2004	CA2525696A1 Control of function of intracellular ca ion
12/02/2004	CA2524936A1 Compositions and methods for the preparation of human growth hormone glycosylation mutants
12/01/2004	EP1482053A2 Eukaryotic host cell line in which an endogenous gene has been activated, and uses thereof
12/01/2004	EP1482049A2 A protein tyrosine kinase.
12/01/2004	EP1482046A2 G-CSF analog compositions and methods
12/01/2004	EP1482045A2 G-CSF analog compositions and methods
12/01/2004	EP1482044A2 Multivariant IL-3 hematopoiesis fusion protein
12/01/2004	EP1482042A1 Active and inactive CC-chemokine receptors and nucleic acid molecules encoding said receptor
12/01/2004	EP1482041A1 Nnl6 tie receptor tyrosine kinase ligand homologues
12/01/2004	EP1482040A2 NL3 TIE receptor tyrosine kinase ligand homologues
12/01/2004	EP1482038A1 Novel protein and dna thereof
12/01/2004	EP1482031A1 Serum-free mammalian cell culture medium, and uses thereof
12/01/2004	EP1481989A1 A-33 related antigens and their pharmacological uses
12/01/2004	EP1481245A1 Determination of compatibility of a set of chemical modifications with an amino-acid chain
12/01/2004	EP1481069A2 Lis promoter for expression of transgenes in floral tissues
12/01/2004	EP1481059A1 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
12/01/2004	EP1481057A1 System and method for the production of recombinant glycosylated proteins in a prokaryotic host
12/01/2004	EP1481053A2 Method of making cs6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections
12/01/2004	EP1481011A1 Monoclonal and polyclonal antibodies recognizing coagulase-negative staphylococcal proteins
12/01/2004	EP1481010A2 Anti-interleukin-1 beta analogs
12/01/2004	EP1481008A2 Anti-amyloid beta antibodies and their use
12/01/2004	EP1481004A2 Streptavidin-binding peptide
12/01/2004	EP1480997A2 Haemophilus adherence and penetration proteins
12/01/2004	EP1480665A2 Peptides for recognition and targeting of glial cell tumors
12/01/2004	EP1480598A2 Manipulation of cytokine levels using cd83 gene products
12/01/2004	EP1423400A4 Evolving new molecular function
12/01/2004	EP1189631B1 Neurodegenerative disorder related gene
12/01/2004	EP1121449A4 Delivery system for porcine somatotropin
12/01/2004	EP0961838A4 Reading frame independent epitope tagging
12/01/2004	EP0917571B1 Agouti-related gene
12/01/2004	EP0912611B9 Human monoclonal antibodies to the hepatitis b surface antigen
12/01/2004	EP0845540B1 Monoclonal antibody and antigen relating to human pulmonary adenocarcinoma and immunoassay method with the use of the same
12/01/2004	EP0720650B1 Human metabotropic glutamate receptor subtype hmglur7 and related dna compounds
12/01/2004	CN1551919A 治疗性结合分子 Therapeutic binding molecules
12/01/2004	CN1551887A Novel depsipeptides and process for preparing same
12/01/2004	CN1551886A Specific human antibodies for selective cancer therapy
12/01/2004	CN1550550A Oncogene, recombinant protein derived therefrom, and uses thereof
12/01/2004	CN1550504A Process of high purity albumin production
12/01/2004	CN1550502A Signal sequences for the production of Leu-hirudine via secretion by E. coli in a culture medium
12/01/2004	CN1177862C Human NIP2 associated protein and coding sequence and application thereof
12/01/2004	CN1177616C Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof
11/2004
11/30/2004	US6825328 Lafora's disease gene
11/30/2004	US6825324 Antibodies to receptor protein tyrosine kinases
11/30/2004	US6825322 Human N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses therefor
11/30/2004	US6825321 For breeding cold-avoidance plants; treatment of diabetes metllitus/obesity; development of thermogenic bio-materials
11/30/2004	US6825318 Vaccine for obesity therapy; hybrid polypeptides
11/30/2004	US6825020 GANP protein
11/30/2004	US6825008 Expressed ligand—vascular intercellular signalling molecule
11/30/2004	US6825006 Preparing an insect-resistant plant, genetic engineered insecticides, crystal protein from culturing the cells, encoding endotoxins having insecticidal activity
11/30/2004	US6824989 Screening/detection of disease for diagnosis/research; genetic engineering; electrophoresis
11/30/2004	US6824978 Regulation of endogenous gene expression in cells using zinc finger proteins
11/30/2004	US6824782 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability

1 ... 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 ... 1125